Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000038777-25-000007
Filing Date
2025-01-27
Accepted
2025-01-27 12:58:21
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 24118
  Complete submission text file 0000038777-25-000007.txt   26150
Mailing Address FRANKLIN RESOURCES INC ONE FRANKLIN PARKWAY SAN MATEO CA 94403
Business Address ONE FRANKLIN PARKWAY BUILDING 920/2, LEGAL-FRI SECRETARY SAN MATEO CA 94403 650-312-2000
FRANKLIN RESOURCES INC (Filed by) CIK: 0000038777 (see all company filings)

EIN.: 132670991 | State of Incorp.: DE | Fiscal Year End: 0930
Type: SCHEDULE 13G/A
SIC: 6282 Investment Advice
(CF Office: 02 Finance)

Mailing Address 480 PLEASANT STREET SUITE B300 WATERTOWN MA 02472
Business Address 480 PLEASANT STREET SUITE B300 WATERTOWN MA 02472 617-926-5000
EyePoint Pharmaceuticals, Inc. (Subject) CIK: 0001314102 (see all company filings)

EIN.: 262774444 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-81613 | Film No.: 25556954
SIC: 3826 Laboratory Analytical Instruments
(CF Office: 08 Industrial Applications and Services)